Results 131 to 140 of about 12,210 (151)

Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study

Acta Ophthalmologica, 2022
Andreas Stahl, Wolf A Lagrèze, Tim U Krohne   +2 more
exaly  

Ranibizumab

Reactions Weekly, 2009
openaire   +2 more sources

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Lancet, The, 2019
Andreas Stahl, Domenico Lepore, Alistair Fielder   +2 more
exaly  

Persisent ocular hypertension following intravitreal ranibizumab

Graefe's Archive for Clinical and Experimental Ophthalmology, 2008
Sophie J Bakri, Colin A Mccannel, Albert O Edwards   +2 more
exaly  

Ranibizumab

Reactions Weekly, 2010
openaire   +1 more source

Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for wet age-related macular degeneration: A systematic review and meta-analysis

Photodiagnosis and Photodynamic Therapy, 2018
Yu Gu
exaly  

Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology, 2018
Emine Alyamac Sukgen, Yusuf Koçluk, Koçluk Yusuf   +2 more
exaly  

<p>Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date</p>

Clinical Ophthalmology, 2020
Eric R Chen, Peter K Kaiser
exaly  

Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity

Ophthalmology, 2017
Yu Xu, Jiao Lyu, Xunda Ji
exaly  

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye

Eye, 2011
W M Sutherland, Nicola G Ghazi
exaly